Results 31 to 40 of about 1,007,573 (266)

Proteotoxic Stress and Cell Death in Cancer Cells

open access: yesCancers, 2020
To maintain proteostasis, cells must integrate information and activities that supervise protein synthesis, protein folding, conformational stability, and also protein degradation. Extrinsic and intrinsic conditions can both impact on normal proteostasis, causing the appearance of proteotoxic stress.
Brancolini C., Iuliano L.
openaire   +2 more sources

Cell Death in the Origin and Treatment of Cancer [PDF]

open access: yesMolecular Cell, 2020
Cell death, or, more specifically, cell suicide, is a process of fundamental importance to human health. Throughout our lives, over a million cells are produced every second. When organismal growth has stopped, to balance cell division, a similar number of cells must be removed.
Andreas, Strasser, David L, Vaux
openaire   +2 more sources

Immunogenic cell death in cancer immunotherapy

open access: yesBMB Reports, 2023
Cancer immunotherapy has been acknowledged as a new paradigm for cancer treatment, with notable therapeutic effects on certain cancer types. Despite their significant potential, clinical studies over the past decade have revealed that cancer immunotherapy has low response rates in the majority of solid tumors.
Minji Choi   +7 more
openaire   +2 more sources

LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes

open access: yesCell Reports, 2015
Ubiquitination and deubiquitination are crucial for assembly and disassembly of signaling complexes. LUBAC-generated linear (M1) ubiquitin is important for signaling via various immune receptors.
Peter Draber   +13 more
doaj   +1 more source

Zinc Finger Transcription Factor MZF1—A Specific Regulator of Cancer Invasion

open access: yesCells, 2020
Over 90% of cancer deaths are due to cancer cells metastasizing into other organs. Invasion is a prerequisite for metastasis formation. Thus, inhibition of invasion can be an efficient way to prevent disease progression in these patients.
Ditte Marie Brix   +2 more
doaj   +1 more source

Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics

open access: yesOncoImmunology, 2017
The expression “immunogenic cell death” (ICD) refers to a functionally unique form of cell death that facilitates (instead of suppressing) a T cell-dependent immune response specific for dead cell-derived antigens. ICD critically relies on the activation
Abhishek D. Garg   +8 more
doaj   +1 more source

Plasma membrane integrity in health and disease: significance and therapeutic potential

open access: yesCell Discovery, 2021
Maintenance of plasma membrane integrity is essential for normal cell viability and function. Thus, robust membrane repair mechanisms have evolved to counteract the eminent threat of a torn plasma membrane.
Catarina Dias, Jesper Nylandsted
doaj   +1 more source

Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis

open access: yesCell Reports, 2017
Summary: We describe a mechanism by which the anti-apoptotic B cell lymphoma 2 (Bcl-2) protein is downregulated to induce apoptosis. ARTS (Sept4_i2) is a tumor suppressor protein that promotes cell death through specifically antagonizing XIAP (X-linked ...
Natalia Edison   +11 more
doaj   +1 more source

Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis

open access: yesNature Communications, 2022
Autophagy is essential to endothelial cell homeostasis. Here the authors show that lipophagy in LEC supports fatty acid oxidation to sustain a mitochondrial-Prox1 gene expression circuit and promote response of LEC to lymphangiogenic mediators.
Odeta Meçe   +22 more
doaj   +1 more source

Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species

open access: yesAntioxidants, 2021
Sorafenib and regorafenib, multikinase inhibitors (MKIs) used as standard chemotherapeutic agents for hepatocellular carcinoma (HCC), generate reactive oxygen species (ROS) during cancer treatment.
Blanca Cucarull   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy